First in-body genome editing trial appears safe
Preliminary results from the first clinical trial to use genome editing directly in the body suggest that the technique is safe...
Dr Charlotte Spicer is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is currently working as a postdoctoral researcher at University College London's Queen Square Institute of Neurology, investigating a gene therapy approach for the rare neurodegenerative disorder spinal bulbar muscular atrophy (also known as Kennedy's disease). Previously, she studied Neuroscience at the University of Leeds, with a year’s industrial experience with the London Pain Consortium at Imperial College London. After this she undertook a PhD in which she investigated the effects of upregulating the heat shock response in models of a rare muscle-wasting disease called inclusion body myositis. This was conducted under the the supervision of Professor Linda Greensmith and funded by the Medical Research Council's Centre for Neuromuscular Diseases at UCL.
Preliminary results from the first clinical trial to use genome editing directly in the body suggest that the technique is safe...
US scientists have successfully delivered CRISPR genome editing components to human sperm cells for the first time...
Researchers have successfully filmed the division of stem cells in an adult mouse brain, for the first time...
Scientists have successfully used gene therapy to prevent bleeding in a small trial of patients with the inherited blood disorder haemophilia B...
A new gene therapy has halted the progression of a fatal degenerative brain disease in a small study of affected boys...
Scientists have published their study confirming they are the first to correct a disease-causing mutation in human embryos using genome editing...
Scientists in the US may have successfully used genome editing in human embryos to correct disease mutations, according to a report by MIT Technology Review...
Genome-wide analysis in South Asian populations may provide insight into rare genetic diseases, suggests research...
It’s not often a PhD student finds themselves with a whole hour to break for lunch. So when asked to review one of the Wellcome Trust’s 'Packed Lunch' talks, I jumped at the chance to make better use of some rare free time. The monthly event, situated
A new three-in-one blood test could progress personalised treatment for patients with prostate cancer...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.